ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 11 filers reported holding ITERUM THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $346,000 | -43.7% | 1,733,170 | 0.0% | 0.60% | -4.0% |
| Q1 2022 | $615,000 | -9.4% | 1,733,170 | 0.0% | 0.62% | +135.5% |
| Q4 2021 | $679,000 | -29.8% | 1,733,170 | 0.0% | 0.26% | -3.6% |
| Q3 2021 | $967,000 | -75.8% | 1,733,170 | 0.0% | 0.28% | -95.4% |
| Q2 2021 | $4,003,000 | +63.8% | 1,733,170 | 0.0% | 6.01% | +80.5% |
| Q1 2021 | $2,444,000 | -28.7% | 1,733,170 | -50.0% | 3.33% | -6.5% |
| Q4 2020 | $3,428,000 | +88.4% | 3,466,340 | +100.0% | 3.56% | -1.5% |
| Q3 2020 | $1,820,000 | -55.9% | 1,733,170 | -50.0% | 3.62% | +46.2% |
| Q2 2020 | $4,124,000 | -12.2% | 3,466,340 | +100.0% | 2.47% | -52.1% |
| Q1 2020 | $4,697,000 | -69.9% | 1,733,170 | -50.0% | 5.17% | +2.6% |
| Q4 2019 | $15,598,000 | – | 3,466,340 | – | 5.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 3,466,340 | $4,124,000 | 2.47% |
| New Leaf Venture Partners, L.L.C. | 1,456,303 | $1,733,000 | 0.50% |
| FRAZIER MANAGEMENT LLC | 1,538,316 | $1,831,000 | 0.16% |
| ARMISTICE CAPITAL, LLC | 1,262,553 | $1,502,000 | 0.07% |
| McAdam, LLC | 12,000 | $14,000 | 0.00% |
| UBS OCONNOR LLC | 88,009 | $105,000,000 | 0.00% |
| Cypress Capital Management LLC (WY) | 1,000 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 96 | $0 | 0.00% |
| Bollard Group LLC | 3,010 | $4,000 | 0.00% |